Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - adam+waickman
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Rapid, robust, and near point-of-care saliva-based nucleic acid detection of dengue virus infections
This technology enables rapid, non-invasive detection and differentiation of all four dengue virus serotypes using saliva samples, with advanced qPCR and RT-LAMP assays, making dengue diagnosis easier, faster, and more accessible without the need for blood draws. Background: Dengue virus (DENV) is a major global health concern, with hundreds of millions...
Published: 1/29/2026
|
Inventor(s):
Frank Middleton
,
Stephen Thomas
,
Adam Waickman
,
Timothy Rooney
Keywords(s):
diagnostics
,
disease diagnosis
,
isothermal amplification (LAMP)
,
nucleic acid
,
PCR
,
RNA viruses
,
saliva
,
Technologies
Category(s):
Campus > Upstate Medical University
,
Technology Classifications > Screens and Assays
,
Technology Classifications > Biomedical Science and Engineering
Multiplexed Saliva-based Immunodiagnostics for Assessing Anti-flavivirus Immunity
An easy-to-use method for rapidly, accurately, and non-invasively assessing flavivirus immunity by measuring various antibody classes present in saliva. Background: Flaviviruses (including dengue virus) are the most common vector-borne human viral pathogens in the world. Nearly 40% of the world’s population are at risk of infection with dengue...
Published: 1/29/2026
|
Inventor(s):
Adam Waickman
,
Stephen Thomas
,
Frank Middleton
Keywords(s):
antibodies
,
antibody
,
infectious diseases
,
saliva
,
Technologies
,
viral immunology
Category(s):
Campus > Upstate Medical University
,
Technology Classifications
,
Technology Classifications > Biomedical Science and Engineering
,
Technology Classifications > Healthcare
,
Technology Classifications > Therapeutics and Vaccines
IgA Monoclonal Antibodies as a Prophylactic and Therapeutic Treatment for Dengue Virus Infection
Enables the prevention and treatment of dengue by avoiding the challenge of Antibody Dependent Enhancement. Background: Dengue virus is one of the most widespread vector-borne viral pathogens in the world. Nearly 400 million dengue virus infections occur each year, resulting in approximately 20,000 deaths. In addition, dengue-associated illness comprises...
Published: 8/21/2025
|
Inventor(s):
Adam Waickman
,
Adam Wegman
,
Jeffrey Currier
,
Heather Friberg
,
Michael McCracken
,
Gregory Gromowski
Keywords(s):
antibody
,
antibody therapy
,
biologics
,
biomedical
,
disease prevention
,
immunotherapy
,
monoclonal antibody
,
Technologies
,
viral immunology
,
viral pathogenesis
Category(s):
Technology Classifications > Therapeutics and Vaccines
,
Technology Classifications > Antibodies
,
Technology Classifications > Healthcare
,
Campus > Upstate Medical University
Personalized Medicine Using Additive Manufacturing
THE CHALLENGE A major problem posed by the pharmaceutical industry is giving effective dosages while not giving excessive amounts of a particular drug. An estimated 80% of side effects in humans and animals are a direct result of inaccurate dosing because varying weights in patients. Additive manufacturing has emerged as a very promising method to...
Published: 6/26/2025
|
Inventor(s):
Emily Wilts
,
Timothy Long
,
Christopher Williams
,
Da Ma
Keywords(s):
Category(s):
Technology Classifications > Additive Manufacturing
,
Technology Classifications > Biomedical
,
Technology Classifications > Chemicals/Materials
,
Technology Classifications > Pharmacology and Therapeutics